Results 161 to 170 of about 27,184 (256)

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consort

The Lancet HIV
D. Byonanebye, M. Polizzotto, Fernando Maltez, Andri Rauch, K. Grabmeier-Pfistershammer, F. Wit, S. de Wit, A. Castagna, A. d’Arminio Monforte, C. Mussini, J. Wasmuth, E. Fontas, I. Abela, Mario Sarcletti, L. Bansi-Matharu, N. Jaschinski, Lars Peters, Sean R Hosein, V. Vannappagari, Cal Cohen, Emiliano Bissio, A. Mocroft, M. Law, L. Ryom, K. Petoumenos   +24 more
semanticscholar   +1 more source

Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People Living with HIV Aged 50 Years and Older: A Retrospective Analysis of Naïve and Treatment-Experienced Individuals. [PDF]

Viruses
Trizzino M, Pipitò L, Di Figlia F, Bonura S, Zimmerhofer F, Cicero A, Gioè C, Cascio A.   +7 more
europepmc   +1 more source

Characterizing treatment interruptions in the OPERA cohort and virologic outcomes after resumption with bictegravir/emtricitabine/tenofovir alafenamide. [PDF]

AIDS Res Ther
Mounzer K, Osterman MD, Brunet L, Hsu RK, Pierone G, Fusco JS, Prata Menezes N, Gruber J, Lim T, Dunbar M, Fusco GP.   +10 more
europepmc   +1 more source

Bictegravir/emtricitabine/tenofovir alafenamide as first-line treatment in naïve HIV patients in a rapid-initiation model of care: BIC-NOW clinical trial.

International Journal of Antimicrobial Agents
C. H. Tenorio, Sergio Sequera, M. Vivancos, D. Vinuesa, Antonio Collado, I. Santos, Patricia Sorni, Noemí Cabello-Clotet, M. Montero, Carlos Ramos Font, A. Terrón, MJ Galindo, O. Martínez, P. Ryan, Mohamed Omar-Mohamed, Helena Albendín Iglesias, Rosario Javier, M. Ruz, A. Romero, Coral García Vallecillos   +19 more
semanticscholar   +1 more source

Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment. [PDF]

Open Forum Infect Dis
Díaz-García C, Serrano-Villar S, G García-Ruiz de Morales A, Güerri-Fernández R, Pérez-Somarriba J, Sánchez Palomino S, Suárez-García I, Hernández Gutiérrez C, Dalmau Juanola D, Moreno S, Moreno E, Martínez-Sanz J.   +11 more
europepmc   +1 more source

Improvement in kidney function in patients with chronic hepatitis B and chronic kidney disease after switching to tenofovir alafenamide fumarate: a systematic review with single arm meta-analysis. [PDF]

J Bras Nefrol
Pascoa Junior JG, Huntermann R, Gomes VMV, Mendes Filho FSM, Bertozzi JMV, Lins PRG.   +5 more
europepmc   +1 more source

Efficacy and safety of switching from lopinavir/ritonavir-based regimens to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV: A multicenter retrospective study. [PDF]

Virol Sin
Fu J, Guo Y, Zheng G, Yang Z, Shi J, Yan D, Yu J, Sun L, Zhao H.   +8 more
europepmc   +1 more source

Longitudinal Evaluation of Bone Safety in Children and Adolescents With HIV-1 Starting Tenofovir Alafenamide-Containing Antiretroviral Therapy. [PDF]

J Pediatric Infect Dis Soc
Natukunda E, Gaur AH, Deville JG, Kosalaraksa P, Strehlau R, Castaño E, Liberty A, Crowe S, Palaparthy R, Vieira VA, Kersey K, Rakhmanina N, Gordon CM.   +12 more
europepmc   +1 more source

Tenofovir alafenamide induced alopecia in an African American female: A case report to raise awareness on possible racial predisposition. [PDF]

JAAD Case Rep
Iloabuchi VC, Imhof RL, Wieland C, Zeuli JD, Katragadda S, Damodaran SS.   +5 more
europepmc   +1 more source

Effectiveness and Safety of Tenofovir Alafenamide Fumarate in the Prevention of Perinatal Hepatitis B Transmission: A Meta-Analysis

Digestive Diseases and Sciences
Ji Huang, Cong Cheng, Kangxin Li, Chunping Zhu, Youshun Liu   +4 more
semanticscholar   +1 more source